by Usha Govindarajulu | Dec 21, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
December 21, 2022 In an article published on December 14, 2022 in MSN.com, researchers had been studying the effect of COVID-19 and exercise and had found a strong correlation or link between the disease and exercise according to research cited from an article...
by Usha Govindarajulu | Dec 8, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
December 5, 2022 A recent article that appeared December 1 in JAMA Open Network shows the retrospective analysis of Remdesivir treatment for inpatient mortality among COVID-19 patients using insurance claims data amongst 24,856 adults hospitalized between May 1, 2020...
by Usha Govindarajulu | Nov 23, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
Issues in COVID-19 research and statistical analyses (Part XVVXVVIV) November 23, 2022 In an article from November 11, 2022 in Health News from NPR, Rob Stein lays out the likelihood of two new Omicron subvariants, BQ.1 and BQ.11 of SARS-Cov-2 having become dominant...
by Usha Govindarajulu | Nov 9, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
November 9, 2022 In a recent article from November 1 in Science Immunology, the authors reported on their analysis of T-cell immunity four weeks and six months after different vaccination regimens and four weeks after an additional booster vaccination. This was a...
by Usha Govindarajulu | Oct 26, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
October 26, 2022 In a letter to the editor, the authors stated that they previously reported on the incidence of myocarditis in Israel after receipt of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) against coronavirus disease 2019 (Covid-19) to have been the...
